FIGURE

Fig. 2.

ID
ZDB-FIG-220414-24
Publication
Coxam et al., 2022 - Svep1 stabilizes developmental vascular anastomosis in reduced flow conditions
Other Figures
All Figure Page
Back to All Figure Page
Fig. 2.

svep1 loss-of-function sensitises angiogenic remodelling to reduced blood flow. (A) Bilateral quantifications of the percentage of gaps in the DLAV at 48 hpf in embryos injected with MO-CTL (5 ng) and MO-svep1 (5 ng) and treated with 0× (n=14 MO-CTL, n=20 MO-svep1), 0.5× (n=16 MO-CTL, n=24 MO-svep1), 1× (n=22 MO-CTL, n=27 MO-svep1) or 2× (n=21 MO-CTL, n=27 MO-svep1) from 30 to 48 hpf (N=3). (B) Bilateral quantifications of the percentage of lumenised segments in the DLAV at 48 hpf in embryos injected with MO-CTL (5 ng) and MO-svep1 (5 ng) and treated with 0× (n=14 MO-CTL, n=20 MO-svep1), 0.5× (n=16 MO-CTL, n=24 MO-svep1), 1× (n=22 MO-CTL, n=27 MO-svep1) or 2× (n=21 MO-CTL, n=27 MO-svep1) from 30 to 48 hpf (N=3). (C) Bilateral quantifications of the percentage of gaps in the DLAV at 48 hpf in embryos injected with MO-CTL (5 ng) (n=13), MO-gata1 (8 ng) (n=12), MO-svep1 (5 ng) (n=16) and MO-gata1 (8 ng)/MO-svep1 (5 ng) (n=25) (N=3). (D) Bilateral quantifications of the percentage of lumenised segments in the DLAV at 48 hpf in embryos injected with MO-CTL (5 ng) (n=13), MO-gata1 (8 ng) (n=12), MO-svep1 (5 ng) (n=16) and MO-gata1 (8 ng)/MO-svep1 (5 ng) (n=25) (N=3). (E) Bilateral quantifications of the percentage of gaps in the DLAV at 48 hpf in embryos injected with MO-CTL (5 ng) (n=11), MO-tnnt2a (4 ng) (n=12), MO-svep1 (5 ng) (n=12) and MO-tnnt2a (4 ng)/MO-svep1 (5 ng) (n=21) (N=3). (F) Bilateral quantifications of the percentage of lumenised segments in the DLAV at 48 hpf in embryos injected with MO-CTL (5 ng) (n=11), MO-tnnt2a (8 ng) (n=12), MO-svep1 (5 ng) (n=12) and MO-tnnt2a (4 ng)/MO-svep1 (5 ng) (n=21) (N=3). (G) Maximum intensity projection of dorsal view of the DLAV from representative embryos injected with MO-CTL (5 ng) (n=11), MO-tnnt2a (8 ng) (n=12), MO-svep1 (5 ng) (n=12) and MO-tnnt2a (4 ng)/MO-svep1 (5 ng) (n=21) embryos at 48 hpf. Red asterisks indicate gaps. (H) Bright-field images of klf2a in situ hybridisation of 48 hpf embryos injected with MO-CTL or MO-svep1 and treated with 0× or 2× tricaine from 30 to 48 hpf. Data are mean±s.d. Mann–Whitney test. Scale bars: 10 μm (G); 50 μm (H).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Development